From: Bile acid distributions, sex-specificity, and prognosis in colorectal cancer
 |  | Females (RCC vs LCC) | Males (RCC vs LCC) | ||
---|---|---|---|---|---|
 |  | FCa | P valueb | FCa | P valueb |
Primary BAs | CA | 7.4 | 0.036 | 7.4 | 0.011 |
CDCA* | – | ns | 6.5 | 0.011 | |
Taurine-conjugated primary BAs | TCA | 33.1 | 0.036 | 14.0 | 0.041 |
TCDCA | 16.7 | 0.036 | 14.2 | 0.012 | |
Glycine-conjugated primary BAs | GCA* | – | ns | 7.8 | 0.020 |
GCDCA | 14.6 | 0.041 | 10.6 | 0.011 | |
Secondary BAs | DCA* | – | ns | 3.4 | 0.011 |
LCA* | – | ns | 1.6 | 0.041 | |
UDCA* | – | ns | 3.4 | 0.020 | |
Taurine-conjugated secondary BAs | TDCA* | 7.4 | 0.041 | – | ns |
TLCA | – | ns | – | ns | |
Glycine-conjugated secondary BAs | GDCA* | 19.0 | 0.036 | – | ns |
GLCA | – | ns | – | ns | |
GUDCA* | – | ns | 23.3 | 0.011 |